Lobbying client

EBITDA CAPITAL

Work with FDA for treatment approval

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
23
Filed by
2
Reported in-house
—
Reported by firms
$100,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2008 to 2011

Filings

23 filings, newest first.
Filing Filed by Amount
1st Quarter - Report
1st Quarter 2010
ADVANTAGE ASSOCIATES INTERNATIONAL — reported
1st Quarter - Report
1st Quarter 2010
EBITDA CAPITAL, LLC — reported
4th Quarter - Report
4th Quarter 2009
EBITDA CAPITAL, LLC — reported
4th Quarter - Report
4th Quarter 2009
ADVANTAGE ASSOCIATES INTERNATIONAL — reported
3rd Quarter - Report
3rd Quarter 2009
EBITDA CAPITAL, LLC — reported
3rd Quarter - Report
3rd Quarter 2009
ADVANTAGE ASSOCIATES INTERNATIONAL $30,000 reported
Registration
3rd Quarter 2009
EBITDA CAPITAL, LLC — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2009
ADVANTAGE ASSOCIATES INTERNATIONAL — reported
1st Quarter - Report (No Activity)
1st Quarter 2009
ADVANTAGE ASSOCIATES INTERNATIONAL — reported
4th Quarter - Report
4th Quarter 2008
ADVANTAGE ASSOCIATES INTERNATIONAL — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ADVANTAGE ASSOCIATES INTERNATIONAL 10 $100,000
EBITDA CAPITAL, LLC In-house 9 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.